Protocol of the adaptive study of IL-2 dose frequency on regulatory T cells in type 1 diabetes (DILfrequency): a mechanistic, non-randomised, repeat dose, open-label, response-adaptive study
Article in BMJ Open (December 2015)
The most recent citing publication is shown below. View this citation on Dimensions.